Clinical Trial

Exploring the Physiological Mechanisms of Austism Through Organoids

Study acronym: EXPECT HYPE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder affecting approximately 1% of the population, characterized by difficulties with social interaction and communication. Studies have identified more than 200 genes linked to ASD, particularly those involved in chromatin remodeling and synaptic neuronal connectivity (CHD8, SCN2A, NLGN3-4X, SHANK1-3). The goal of the project is to decipher the biological mechanisms underlying ASD in order to develop therapeutic strategies, using innovative preclinical models such as organoids.
Trial Details
NCT Number NCT07494331
Lead Sponsor Assistance Publique - Hôpitaux de Paris
Conditions Autism Spectrum Disorder (ASD
Enrollment 80 participants
Start Date 2026-05-01
Primary Completion 2028-05-01 (estimated)
Study Completion 2028-05-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-27